NCT01457924 · Interventional trial
Ofatumumab Subcutaneous Administration in Subjects With Relapsing-Remitting Multiple Sclerosis
Overall registry status Completed
Phase 2
Conditions Multiple Sclerosis
Delaware Valley sites
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory